id author title date pages extension mime words sentences flesch summary cache txt work_xsvwzurwvngfnj4ubi324mvlje Michael R. Bishop Donor Lymphocyte Infusion: Beauty Is in the Eye of the Beholder 2013 2 .pdf application/pdf 1662 149 57 In this issue of Biology Of Blood and Marrow Transplantation, Bar et al. effect of CD3รพ cell dose in initial donor lymphocyte infusion (DLI) on graft-versus-host disease (GVHD) and overall survival in 225 patients who received DLI for relapsed hematologic malignancy, primarily at the Fred Hutchison Cancer context of our other options for recurrent disease after allogeneic hematopoietic cell transplantation. treatment of leukemia relapsing after allogeneic bone marrow transplantation. leukemia relapse after allogeneic bone marrow transplantation. relapse after allogeneic bone marrow transplantation. chronic myelogenous leukemia after allogeneic bone marrow transplantation. malignancies after allogeneic stem-cell transplantation. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone Donor lymphocyte infusion in the treatment of first hematological relapse after allogeneic stem-cell transplantation in adults with Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell relapse after allogeneic stem cell transplantation. ./cache/work_xsvwzurwvngfnj4ubi324mvlje.pdf ./txt/work_xsvwzurwvngfnj4ubi324mvlje.txt